Last reviewed · How we verify

NCT03523611

Right Ventricular Inflammation After Lung Resection

Status unknown Last updated 29 May 2018
What this trial tests

trial testing Lung Resection in Lung Cancer in 15 participants. Status unknown.

Timeline
30 April 2018
Primary endpoint
19 April 2019
1 August 2019

Quick facts

Lead sponsorUniversity of Glasgow
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment15
Start date30 April 2018
Primary completion19 April 2019
Estimated completion1 August 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Glasgow

Who can join

16 and older, any sex, with Lung Cancer or Ventricular Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is explore the impact of lung cancer surgery on inflammation and function of the right side of the heart.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

Other University of Glasgow trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03523611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing